Clinical Trials Browser

Phase 2 × Unresectable Locally Recurrent Breast Cancer × 30 days × Clear all

NCT07497386 2026-05-11

A Trial of Trastuzumab Rezetecan in Unresectable Locally Recurrent/Metastatic Breast Cancer

Phase 2 Recruiting

Unresectable Locally Recurrent Breast Cancer